These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32616655)
21. Evidence-Based Development and Clinical Use of Precision Oncology Therapeutics. Comment LA; Ward AF; Schrock AB; Fabrizio D; Venstrom JM; Hegde PS; Alexander BM Clin Pharmacol Ther; 2020 Sep; 108(3):440-443. PubMed ID: 32744335 [No Abstract] [Full Text] [Related]
22. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy. Farwell MD; Clark AS; Mankoff DA JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243 [No Abstract] [Full Text] [Related]
24. The Future of Precision Oncology for the Treatment of Solid Tumors. Klute KA Clin Pharmacol Ther; 2020 Sep; 108(3):416-418. PubMed ID: 31983061 [No Abstract] [Full Text] [Related]
25. Targetable long non-coding RNAs in cancer treatments. Chen L; Dzakah EE; Shan G Cancer Lett; 2018 Apr; 418():119-124. PubMed ID: 29341880 [TBL] [Abstract][Full Text] [Related]
26. Rare Mutations in Cancer Drug Resistance and Implications for Therapy. Beckman RA; Loeb LA Clin Pharmacol Ther; 2020 Sep; 108(3):437-439. PubMed ID: 32648584 [No Abstract] [Full Text] [Related]
27. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice. Beer PA; Cooke SL; Chang DK; Biankin AV Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210 [No Abstract] [Full Text] [Related]
28. Biomarkers of Bad Biology: Curse or a Blessing? Banerjee S; Sicklick JK Ann Surg Oncol; 2019 Feb; 26(2):318-320. PubMed ID: 30539488 [No Abstract] [Full Text] [Related]
29. Delivering on the promise of precision cancer medicine. Berger MF; Van Allen EM Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852 [No Abstract] [Full Text] [Related]
30. Targeted therapy in cancer. Tsimberidou AM Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154 [TBL] [Abstract][Full Text] [Related]
31. The past, present, and future of HER2 (ERBB2) in cancer: Approaches to molecular testing and an evolving role in targeted therapy. Hechtman JF; Ross DS Cancer Cytopathol; 2019 Jul; 127(7):428-431. PubMed ID: 30938930 [No Abstract] [Full Text] [Related]
33. Precision medicine: lessons learned from the SHIVA trial. Hahn AW; Martin MG Lancet Oncol; 2015 Dec; 16(16):e580-1. PubMed ID: 26678198 [No Abstract] [Full Text] [Related]
34. Precision medicine: lessons learned from the SHIVA trial. Tsimberidou AM; Kurzrock R Lancet Oncol; 2015 Dec; 16(16):e579-80. PubMed ID: 26678197 [No Abstract] [Full Text] [Related]
35. Expansion platform type II: testing a treatment strategy. Catenacci DV Lancet Oncol; 2015 Oct; 16(13):1276-8. PubMed ID: 26342235 [No Abstract] [Full Text] [Related]
36. Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer Management. Lieu CH; Corcoran RB; Overman MJ Am Soc Clin Oncol Educ Book; 2019 Jan; 39():207-215. PubMed ID: 31099678 [TBL] [Abstract][Full Text] [Related]
37. Collagen XI alpha 1 chain, a potential therapeutic target for cancer. Liu Z; Lai J; Jiang H; Ma C; Huang H FASEB J; 2021 Jun; 35(6):e21603. PubMed ID: 33999448 [TBL] [Abstract][Full Text] [Related]
38. Quinazoline compounds for antitumor treatment. Solyanik GI Exp Oncol; 2019 Mar; 41(1):3-6. PubMed ID: 30932417 [TBL] [Abstract][Full Text] [Related]
39. TQuest, A Web-Based Platform to Enable Precision Medicine by Linking a Tumor's Genetic Defects to Therapeutic Options. Gershkovich P; Platt J; Knopf J; Tasoulis MK; Shi W; Pusztai L; Hatzis C JCO Clin Cancer Inform; 2018 Dec; 2():1-13. PubMed ID: 30652574 [TBL] [Abstract][Full Text] [Related]
40. Steps forward for cancer precision medicine. Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D; Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]